Grown Rogue International (GRUSF) Total Current Liabilities (2011 - 2026)
Grown Rogue International (GRUSF) posted quarterly Total Current Liabilities of $8.3 million for Q1 2026, down 44.11% year-over-year from $14.9 million in Q1 2025, and up 45.0% quarter-over-quarter from $5.7 million in Q4 2025.
Grown Rogue International (GRUSF) Total Current Liabilities (2011 - 2026) Analysis & Trends
Grown Rogue International's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 44.11% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (down 44.11% YoY), while the FY2025 annual figure was $5.7 million, down 70.77% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $8.3 million, up from $5.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $6658.1 billion in Q3 2025, with the low at $4.0 million in Q4 2022.
- The 5-year median for Total Current Liabilities is $10.8 million (2023), against an average of $475.6 billion.
- Peak annual rise in Total Current Liabilities reached 43112177.61% in 2025, while the deepest fall reached 70.77% in 2025.
- Grown Rogue International's Total Current Liabilities stood at $4.0 million in 2022, then surged by 116.02% to $8.6 million in 2023, then jumped by 126.56% to $19.6 million in 2024, then slumped by 70.77% to $5.7 million in 2025, then jumped by 45.0% to $8.3 million in 2026.
- Business Quant data shows GRUSF's Total Current Liabilities at $8.3 million in Q1 2026, $5.7 million in Q4 2025, and $6658.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 8.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.71 Mn |
| Mar 31, 2026 | 8.30 Mn |
| Dec 31, 2025 | 5.72 Mn |
| Sep 30, 2025 | 6,658.11 Bn |
| Jun 30, 2025 | 5.82 Mn |
| Mar 31, 2025 | 14.85 Mn |
| Dec 31, 2024 | 19.59 Mn |
| Sep 30, 2024 | 15.44 Mn |
| Jun 30, 2024 | 16.43 Mn |
| Mar 31, 2024 | 19.72 Mn |
| Dec 31, 2023 | 8.65 Mn |
| Oct 31, 2023 | 13.00 Mn |
| Jul 31, 2023 | 8.12 Mn |
| Jan 31, 2023 | 6.54 Mn |
| Oct 31, 2022 | 4.00 Mn |
| Oct 31, 2021 | 1.71 Mn |
| Apr 30, 2021 | 1.73 Mn |
| Jan 31, 2021 | 4.71 Mn |
| Oct 31, 2020 | 489,266.00 |
| Jul 31, 2020 | 2.23 Mn |